BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26448174)

  • 1. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications.
    Ueta M
    Cornea; 2015 Nov; 34 Suppl 11():S158-65. PubMed ID: 26448174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.
    Ueta M
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES183-DES191. PubMed ID: 30481825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions.
    Ueta M
    Taiwan J Ophthalmol; 2016; 6(3):108-118. PubMed ID: 29018724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.
    Wakamatsu TH; Ueta M; Tokunaga K; Okada Y; Loureiro RR; Costa KA; Sallum JMF; Milhomens JA; Inoue C; Sotozono C; Gomes JÁP; Kinoshita S
    JAMA Ophthalmol; 2017 Apr; 135(4):355-360. PubMed ID: 28278336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.
    Ueta M; Sawai H; Sotozono C; Hitomi Y; Kaniwa N; Kim MK; Seo KY; Yoon KC; Joo CK; Kannabiran C; Wakamatsu TH; Sangwan V; Rathi V; Basu S; Ozeki T; Mushiroda T; Sugiyama E; Maekawa K; Nakamura R; Aihara M; Matsunaga K; Sekine A; Gomes JÁ; Hamuro J; Saito Y; Kubo M; Kinoshita S; Tokunaga K
    J Allergy Clin Immunol; 2015 Jun; 135(6):1538-45.e17. PubMed ID: 25672763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing.
    Nakatani K; Ueta M; Khor SS; Hitomi Y; Okudaira Y; Masuya A; Wada Y; Sotozono C; Kinoshita S; Inoko H; Tokunaga K
    Sci Rep; 2019 Nov; 9(1):16240. PubMed ID: 31700100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications.
    Ueta M; Kannabiran C; Wakamatsu TH; Kim MK; Yoon KC; Seo KY; Joo CK; Sangwan V; Rathi V; Basu S; Shamaila A; Lee HS; Yoon S; Sotozono C; Gomes JÁ; Tokunaga K; Kinoshita S
    Sci Rep; 2014 Aug; 4():5981. PubMed ID: 25099678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand.
    Jongkhajornpong P; Lekhanont K; Pisuchpen P; Chantaren P; Puangsricharern V; Prabhasawat P; Suphapeetiporn K; Kinoshita S; Ueta M
    Br J Ophthalmol; 2018 Sep; 102(9):1303-1307. PubMed ID: 29706602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese.
    Ma KS; Chung WH; Hsueh YJ; Chen SY; Tokunaga K; Kinoshita S; Ma DHK; Ueta M
    Br J Ophthalmol; 2022 May; 106(5):610-615. PubMed ID: 33441319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications.
    Ueta M
    Front Med (Lausanne); 2021; 8():649661. PubMed ID: 34926478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens-Johnson syndrome with severe ocular surface complications.
    Ueta M; Tokunaga K; Sotozono C; Sawai H; Tamiya G; Inatomi T; Kinoshita S
    PLoS One; 2012; 7(8):e43650. PubMed ID: 22912896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.
    Ueta M
    Front Med (Lausanne); 2021; 8():651247. PubMed ID: 34869401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
    Okamoto-Uchida Y; Nakamura R; Matsunaga K; Aihara M; Saito Y
    Pharmacogenet Genomics; 2018 Mar; 28(3):95-98. PubMed ID: 29239905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC.
    Ueta M
    Front Genet; 2022; 13():912478. PubMed ID: 35899189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of human antigen class I genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population.
    Jun I; Rim JH; Kim MK; Yoon KC; Joo CK; Kinoshita S; Seo KY; Ueta M
    Br J Ophthalmol; 2019 Apr; 103(4):573-576. PubMed ID: 30705045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular surface inflammation mediated by innate immunity.
    Ueta M; Kinoshita S
    Eye Contact Lens; 2010 Sep; 36(5):269-81. PubMed ID: 20703156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistatic interactions associated with Stevens-Johnson syndrome.
    Ueta M
    Cornea; 2012 Nov; 31 Suppl 1():S57-62. PubMed ID: 23038037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of prostaglandin E
    Mieno H; Ueta M; Yamada K; Yamanaka Y; Nakayama T; Watanabe A; Kinoshita S; Sotozono C
    Br J Ophthalmol; 2020 Jul; 104(7):1022-1027. PubMed ID: 31000507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.